Obstructive sleep apnea hypopnea syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with moderate to severe OSAHS diagnosed by laboratory polysomnography (PSG) cannot tolerate CPAP therapy; 2. The plane of obstruction is in the oropharynx: the pharyngeal cavity is narrow due to hypertrophic mucosal tissue, the uvula is hypertrophic or too long, the soft palate is too low or too long, the tonsils are hypertrophic or the palate is narrow; 3. Male, aged 18 to 65 years; 4. Patients voluntarily participate in this clinical study and sign the informed consent form; they are willing and able to follow up with the program in a timely manner.
Exclusion criteria
Exclusion criteria: 1. OSAHS patients who have received relevant surgical treatment; 2. Patients with severe craniomaxillofacial deformities (examinations indicate that there is no stenosis in other upper airway regions); 3. Those with scar constitution; 4. Patients with heart failure or central sleep apnea hypopnea syndrome; 5. People with coagulation dysfunction; 6. Mental illness or mental disorder; 7. Chronic obstructive pulmonary disease, asthma, chronic bronchitis and other airway inflammatory diseases and rheumatoid and other systemic diseases; 8. The investigator believes that there are any reasons for not being suitable to participate in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| score of assessment scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Apnea hypopnea index; | — |
Countries
China
Contacts
Shanghai Jiao Tong University Affiliated Sixth People’s Hospital